Platelets function as an acute viral reservoir during HIV-1 infection by harboring virus and T-cell complex formation
Open Access
- 18 September 2020
- journal article
- research article
- Published by American Society of Hematology in Blood Advances
- Vol. 4 (18) , 4512-4521
Abstract
Platelets were recently found to harbor infectious HIV virions in infected individuals who are on antiretroviral treatment with poor CD4+ T-cell recovery. In this study, we screened platelets from recently infected individuals, before and after antiretroviral therapy, for the presence of virus and examined platelet activation, as well as CD4+ T-cell recovery. This was followed by in vitro studies assessing platelet–CD4+ T-cell complex formation as a contributing factor to viral transmission. HIV+ platelets were detected in 10 of 10 acutely infected individuals with no prior history of antiretroviral therapy. The percentage of HIV+ platelets dropped significantly after 3 months of antiretroviral therapy in all of the study participants. These individuals also demonstrated significant recovery of CD4+ T cells. Interestingly, the percentage of HIV+ platelets correlated positively with viral load but not with CD4+ T-cell count. Furthermore, we found that platelet activation with soluble CD40L or thrombin receptor activator peptide 6 (TRAP6) increased platelet-virus interactions in vitro. TRAP6-mediated interactions were reduced by platelet antagonists, aspirin, and R406. We demonstrated that platelets transmit the virus to CD4+ T cells, and this transinfection was abolished by inhibiting platelet–T-cell complex formation via exposure to an anti-CD62P antibody. Additionally, treatment with TRAP6 significantly increased the transinfection, which was also inhibited by aspirin and R206. These results reveal that platelets have the potential to promote HIV viral spread during the acute stage of infection, by harboring infectious virus transmitting infection to susceptible CD4+ T cells through complex formation.Keywords
This publication has 43 references indexed in Scilit:
- Platelets and Erythrocyte-Bound Platelets Bind Infectious HIV-1 in Plasma of Chronically Infected PatientsPLOS ONE, 2013
- Platelet activation suppresses HIV-1 infection of T cellsRetrovirology, 2013
- Increased Platelet and Microparticle Activation in HIV InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2012
- DMSO inhibits human platelet activation through cyclooxygenase-1 inhibition. A novel agent for drug eluting stents?Biochemical and Biophysical Research Communications, 2010
- Human Immunodeficiency Virus Type 1 Infection Increases the In Vivo Capacity of Peripheral Monocytes To Cross the Blood-Brain Barrier into the Brain and the In Vivo Sensitivity of the Blood-Brain Barrier to Disruption by LipopolysaccharideJournal of Virology, 2008
- Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapyProceedings of the National Academy of Sciences, 2008
- ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy ViremiaPLOS Pathogens, 2007
- DC-SIGN and CLEC-2 Mediate Human Immunodeficiency Virus Type 1 Capture by PlateletsJournal of Virology, 2006
- Diversity of receptors binding HIV on dendritic cell subsetsNature Immunology, 2002
- Dimethyl sulfoxide: effects on function of fresh platelets and on the viability of platelets in storageTransfusion, 1983